Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

NCT02215005 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Telmisartan
DRUG: Ramipril

Sponsor

Boehringer Ingelheim